Macrophage function in adipose tissue homeostasis and metabolic inflammation
- PMID: 37012544
- DOI: 10.1038/s41590-023-01479-0
Macrophage function in adipose tissue homeostasis and metabolic inflammation
Erratum in
-
Author Correction: Macrophage function in adipose tissue homeostasis and metabolic inflammation.Nat Immunol. 2024 Mar;25(3):576. doi: 10.1038/s41590-023-01726-4. Nat Immunol. 2024. PMID: 38082153 No abstract available.
Abstract
Obesity-related metabolic organ inflammation contributes to cardiometabolic disorders. In obese individuals, changes in lipid fluxes and storage elicit immune responses in the adipose tissue (AT), including expansion of immune cell populations and qualitative changes in the function of these cells. Although traditional models of metabolic inflammation posit that these immune responses disturb metabolic organ function, studies now suggest that immune cells, especially AT macrophages (ATMs), also have important adaptive functions in lipid homeostasis in states in which the metabolic function of adipocytes is taxed. Adverse consequences of AT metabolic inflammation might result from failure to maintain local lipid homeostasis and long-term effects on immune cells beyond the AT. Here we review the complex function of ATMs in AT homeostasis and metabolic inflammation. Additionally, we hypothesize that trained immunity, which involves long-term functional adaptations of myeloid cells and their bone marrow progenitors, can provide a model by which metabolic perturbations trigger chronic systemic inflammation.
© 2023. Springer Nature America, Inc.
References
-
- Bluher, M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15, 288–298 (2019). - PubMed
-
- John, H. J. Summary of findings in 1,100 glucose tolerance estimations. Endocrinology 13, 388–392 (1929).
-
- Emerging Risk Factors Collaboration et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375, 132–140 (2010).
-
- Spranger, J. et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812–817 (2003). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
